Drug Nomenclature

A generic name, or USAN (United States Adopted Name), is the official nonproprietary name assigned after FDA approval and listing in the United States Pharmacopeia. A brand name is the proprietary name or trademark assigned by the manufacturer for marketing. Generic names identify drugs by pharmacological class and are preferred in prescriptions because they save money and improve communication.

Nonproprietary names are preferred because they can save money for patients and are easier to communicate among healthcare providers. Unlike proprietary names, which vary by manufacturer and country, nonproprietary names remain consistent and identify the drug by its pharmacological class, reducing confusion and ensuring clarity in prescriptions.

Yes, the same drug can have multiple proprietary names assigned by different manufacturing companies. Additionally, a single manufacturer may market the same drug under different proprietary names in different countries. Nonproprietary names prove more useful in these situations because they uniquely identify the drug regardless of manufacturer or market.

The FDA has established bioavailability standards to maintain drug quality and ensure desired therapeutic effects. Information about therapeutic equivalence evaluation is compiled in official publications for reference. These standards ensure that drugs meet consistent quality requirements and deliver reliable therapeutic outcomes across different manufacturers and formulations.

After FDA approval, a drug receives a USAN (United States Adopted Name), which is the official nonproprietary generic name. Once the drug is listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official designation. The manufacturer also assigns a proprietary brand name for marketing purposes.

Drug nomenclature provides the standardized naming system used across all drug categories. Understanding generic and proprietary names is essential when distinguishing between prescription nonprescription and orphan drugs, as nonproprietary names help identify drug class and therapeutic use regardless of prescription status or manufacturer.

A code name is the initial designation assigned by the manufacturer when a new drug is first developed. This temporary identifier is used during the early development phase before the drug undergoes FDA approval. Once approved, the code name is replaced by the official USAN (United States Adopted Name) and proprietary brand name.